Abstract
Three molecular adducts of the antituberculosis drug isoniazid (INH) are synthesized with γ-resorcylic acid (γRA), phloroglucinol (PG), and gallic acid (GA). The new solid phases are preliminarily characterized by the thermal analysis (DSC/TGA) and powder X-ray diffraction. The formation of new solid phases is confirmed by single crystal X-ray diffraction, infrared (FT-IR) and Raman spectroscopy. All three new solid crystalline forms are stabilized by various hydrogen bonding interactions such as N+···H–O–, N···H–O, O···H–O, and π–π stacking. The FT-IR analysis puts forward that the solid form of INH1 is a salt whereas the INH2 and INH3 molecular complexes are cocrystals. We have also investigated the density of states (DOS), band structure, and atomic orbit projected density of state (PDOS) of title compounds by adopting the density functional theory (DFT) technique in the local density approximation (LDA). The electronic structure calculations show that energy states are delocalized in the k-space due the hydrogen and covalent bonds in the crystals. The frontier molecular orbital (FMO) analysis reveals that charge transfer takes place within the compounds. The Hirshfeld analysis shows that H–H and N⋯H–O hydrogen bonding interactions are dominant in all three molecular adducts of INH.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
G. R. Desiraju. Acc. Chem. Res., 2002, 35,565.
B. Moulton and M. J. Zaworotko. Chem. Rev., 2001, 101, 1629–1658.
L. MacGillivray. CrystEngComm., 2004, 6, 77/78.
C. B. Aakeroy and D. J. Salmon. CrystEngComm, 2005, 7, 439–448.
M. C. Etter. Acc. Chem. Res., 1990, 23, 120–126.
P. Sanphui, G. Bolla, and A. Nangia. Cryst. Growth Des., 2012, 12(4), 2023–2036.
F. T. Martins, R. Bonfilio, M. B. D. Araujo, and J. Ellena. J. Pharm. Sci., 2012, 101, 2143–2154.
A. T. M. Serajuddin. Adv. Drug Delivery Rev., 2007, 59, 603–616.
A. Lemmerer. CrystEngComm, 2012, 14, 2465–2478.
Ö. Almarsson and M. J. Zaworotko. Chem. Commun., 2004, 0, 1889–1896.
N. Blagden, M. de Matas, P. T. Gavan, and P. York. Adv. Drug Delivery Rev., 2007, 59, 617–630.
P. H. Stahl and C. G. Wermuth. Ed. Verlag Helvetica Chimica Acta, Zurich, 2002.
R. C. Rowe, P. J. Sheskey, and S. C. Owen. Ed. APhA Publications, 5th edn, 2005.
USP DI®, vol. I, 15th ed. 1627, 1995.
A. Lemmerer, J. Bernstein, and V. Kahlenberg. CrystEngComm, 2010, 12, 2856–2864.
P. Grobely, A. Mukherjee, and G. R. Desiraju. CrystEngComm, 2011, 13, 4358–4364.
N. Ravikumar, G. Gopikrishna, and K. Anand Solomon. J. Mol. Struct., 2013, 1033, 272–279.
A. Lemmerer, J. Bernstein, and V. Kahlenberg. J. Chem. Crystallogr., 2011, 41, 991–997.
S. Cherukuveda and A. Nangia. CrystEngComm, 2012, 14, 2579–2588.
J. G. da Silva Filho, V. N. Freire, E. W. S. Caetano, L. O. Ladeira, U. L. Fulco, and E. L. Albuquerque. Chem. Phys. Lett., 2013, 587, 20–24.
X.-G. Meng, Y.-L. Xiao, H. Zhang, and C.-S. Zhou. Acta. Crystallogr., Sect. C, 2008, 64, o261–o263.
I. Sarcevica, L. Orola, M. V. Veidis, A. Podjava, and S. Belyakov. Cryst. Growth Des., 2013, 13, 1082–1090.
N. Saikia, S. K. Pati, and R. C. Deka. Appl. Nanosci., 2012, 2, 389–400.
B. Barbielini and A. Shukla. Phys. Rev. B, 2002, 66, 235101.
Bruker APEX2, SAINT, SADABS. Bruker AXS Inc., Madison, Wisconsin, USA, 2004.
A. Altomare, G. Cascarano, C. Giacovazzo, and A. Guagliardi. J. Appl. Crystallogr., 1993, 26, 343–350.
G. M. Sheldrick. Acta Crystallogr., 2008, A64, 112–122.
M. Segall, P. Linda, M. Probert, C. Pickard, C. Hasnip, S. Clark, and M. Payne. Materials Studio CASTEP, version 2.2. AccelrysSan Diego, CA, 2002.
M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, et al. Gaussian 09, Revision A.02. Gaussian, Inc., Wallingford CT, 2009.
S. K. Wolff, D. J. Grimwood, J. J. McKinnon, D. Jayatilaka, and M. A. Spackman. Crystal Explorer, version 1.5, University of Western Australia: Perth, Australia, 2007.
F. P. A. Fabbiani, L. T. Byrne, J. J. McKinnon, and M. A. Spackman. CrystEngComm, 2007, 9, 728–731.
A. Parkin, G. Barr, W. Dong, C. J. Gilmore, D. Jayatilaka, J. J. McKinnon, M. A. Spackman, and C. C. Wilson. CrystEngComm, 2007, 9, 648–652.
M. A. Elbagerma, H. G. M. Edwards, T. Munshi, M. D. Hargreaves, P. Matousek, and I. J. Scowen. Cryst. Growth Des., 2010, 10, 2360–2371.
S. L. Childs, G. P. Stahly, and A. Park. Mol. Pharmaceutics, 2007, 4, 323–338.
R. M. Silverstein and F. X. Webster. Spectrometric identification of organic compounds 6th edn. Wiley, New York, 1998.
E. Spinner. J. Chem. Soc., 1962, 10, 3119.
P. Bassignana, C. Cogrossi, and M. Gaudino. Spectrochim. Acta, 1963, 19, 1885–1897.
T. Thakuria and A. Nangia. CrystEngComm, 2011, 13, 1759–1764.
J. F. Remenar, M. L. Peterson, P. W. Stephens, Z. Zhang, Y. Zimenkov, and M. B. Hickey. Mol. Pharmaceutics, 2007, 4, 386–400.
T. A. Koopmans. Atoms Physica, 1934, 1, 104–113.
P. Sjoberg and P. Politzer. J. Phys. Chem., 1990, 94, 3959–3961.
J. J. McKinnon, D. Jayatilaka, and M. A. Spackman. Chem. Commun., 2007, 12, 3814–3816.
M. A. Spackman and D. Jayatilaka. CrystEngComm, 2009, 11, 19–32.
M. J. Turner, J. J. McKinnon, D. Jayatilaka, and M. A. Spackman. CrystEngComm, 2011, 13, 1804–1813.
M. A. Spackman, J. J. McKinnon, and D. Jayatilaka. CrystEngComm, 2008, 10, 377–388.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © 2018 A. S. Kamalakaran.
The text was submitted by the authors in English. Zhurnal Strukturnoi Khimii, Vol. 59, No. 7, pp. 1580–1595, September-October, 2018.
Rights and permissions
About this article
Cite this article
Kamalakaran, A.S. Molecular Adducts of Isoniazid: Crystal Structure, Electronic Properties, and Hirshfeld Surface Analysis. J Struct Chem 59, 1518–1533 (2018). https://doi.org/10.1134/S002247661807003X
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S002247661807003X